Has Brenda Peabody, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,776 in general payments to Brenda Peabody, MD across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brenda Peabody, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brenda Peabody, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brenda Peabody, MD

Cardiovascular Disease · The Woodlands, TXNPI 1861493389

Payments from drug & device makers

$2,776in general payments, 2019–2025

Across 70 payments — averaging $39.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$771
Boston Scientific$680
Tactile Systems Technology Inc$379
Abbott$286
Amgen$258
Impulse Dynamics (USA) Inc.$205
plus $197 from 3 others

What the payments were for

Food & beverage$2,776100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	17	$771
Boston Scientific	22	$680
Tactile Systems Technology Inc	15	$379
Abbott	7	$286
Amgen	4	$258
Impulse Dynamics (USA) Inc.	2	$205
Edwards Lifesciences	1	$105
Bard Peripheral Vascular, Inc.	1	$71
Biotronik Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Repatha$234
VenaSeal$167
ClosureFast$158
OPTIMIZER$157
Flexitouch Plus$146
Entre Plus$146
GENERAL VASCULAR INTERVENTION$121
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$111
Carpentier-Edwards Physio II Annuloplasty Ring$105

How this compares

$2,776 in reported general payments places this provider in the 40th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Medicare billing

Part B allowed, 2024

$419,998

Medicare patients

646

Services billed

2,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	426	$527,795
XareltoRivaroxaban	91	$130,647
MultaqDronedarone Hcl	44	$94,263
EntrestoSacubitril/Valsartan	39	$41,828
Repatha SureclickEvolocumab	28	$29,785
FarxigaDapagliflozin Propanediol	13	$10,131
Metoprolol Succinate	615	$9,940
Flecainide Acetate	119	$5,359
Rosuvastatin Calcium	217	$3,638
Propafenone Hcl ErPropafenone Hcl	18	$3,352
Ezetimibe	126	$3,255
Amiodarone Hcl	142	$2,715
Valsartan	72	$2,641
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide	60	$2,491
Atorvastatin Calcium	268	$2,406

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in The Woodlands

Ramin Farzaneh-FarDallas$17.1M
Jeffrey GladdenDallas$15.8M
Ann NavarDallas$14.5M
David BrabhamAmarillo$11.5M
Justin GrodinDallas$6.2M
Christie BallantyneHouston$4.6M
Syed NaqviHouston$3.6M
Faisal WahidMcKinney$3.4M
James FeldmanHouston$3.1M
Fernando BoccalandroOdessa$3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →